Ohio State University fired the director of its celebrated marching band on Thursday after determining he ignored a "sexualized" culture of rituals including students being pressured to march in their underwear and...More >>
Thursday, July 24 2014 7:03 PM EDT2014-07-24 23:03:53 GMT
With Congress scheduled to recess in a week, the Senate Veterans Affairs Committee's chairman is offering to scale back a Senate-passed bill to improve health care services for veterans.More >>
With Congress scheduled to recess in a week, the chairmen of the House and Senate Veterans Affairs committees offered competing proposals Thursday to fix a veterans' health care program scandalized by long patient wait...More >>
Thursday, July 24 2014 6:35 PM EDT2014-07-24 22:35:09 GMT
Israeli tanks and warplanes are pummeling the Gaza Strip as U.S. and other diplomats push for a cease-fire with Hamas militants.More >>
A U.N. school in Gaza crowded with hundreds of Palestinians seeking refuge from fierce fighting came under fire Thursday, killing at least 15 civilians and leaving a sad tableau of blood-spattered pillows, blankets and...More >>
Thursday, July 24 2014 7:01 PM EDT2014-07-24 23:01:32 GMT
The official Algerian news agency says an Air Algerie flight from Burkina Faso to Algiers has disappeared from the radar.More >>
An Air Algerie jetliner carrying 116 people crashed Thursday in a rainstorm over restive Mali, and its wreckage was found near the border of neighboring Burkina Faso - the third major international aviation disaster in a...More >>
Thursday, July 24 2014 6:48 PM EDT2014-07-24 22:48:15 GMT
Prominent HIV/AIDS researchers were among the 298 victims identified aboard flight MH17. To honor their legacy, the Chattahoochee Valley Better Way Foundation is hosting a candlelight vigil. We spokeMore >>
The Chattahoochee Valley Better Way Foundation to host candlelight vigil to honor top HIV/AIDS researchers killed in Malaysia Airlines Flight 17 on July 18th, 2014. More >>
PHOENIX (CBS5) -
The results of an experimental medication were just released, and it could mean good news for Alzheimer's patients.
The makers of solanezumab said it can slow the progress of Alzheimer's disease by 30 percent if the disease is caught early.
The Alzheimer's Diseases Cooperative Study concluded the medication, produced by Eli Lilly, slowed the rate of cognitive decline and memory loss for patients in the early stages of Alzheimer's.
Experts are excited, but not too excited - yet. Solanezumab has not been approved by the FDA, and critics of the drug said the impact isn't much more than "a hint of activity."
"Unfortunately, there have been many, many, and dozens and dozens of disappointments as these clinical trials come out. But we have hope, and that is the message we want to get out. We want to support research," said Philip Carll of the Alzheimer's Association, Desert SW Chapter.
Ron Casola was diagnosed with early-onset Alzheimer's about two years ago. He's encouraged by the research, but clinical trials in the past have resulted in limited success.
"It would excite me if I knew that it really worked and it was proven. Something that's out, new, that hasn't been proven yet, not so much," Casola said.
Whether this new drug is a success or failure, both Carll and Casola hope this raises more awareness and research. Currently, $450 million is spent on Alzheimer's research. By contrast, cancer receives roughly $6 billion and HIV-AIDS receives $3 billion in research.
"AIDS is a great example. Twenty years ago that was a death sentence. Now people are living long, quality lives," added Carll.
For more information on Alzheimer's, including local support, services and information, CLICK HERE.
Copyright 2012 CBS 5 (Meredith Corporation). All rights reserved.
12 East Delano Avenue
Montgomery, AL 36105